证券记录 · 已归档季度
GKOS
Glaukos Corporation · Healthcare · Medical - Devices
14被追踪持有人
-2Δ持有人
8.81M持有股份
$867.57M报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -12.5% ·
股份流向 -9.5% ·
净新建仓位 -14.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 125 | +9 | 42.85M | $5.95B | +15 | −5 |
| Q1 2026 | 118 | -1 | 46.55M | $5.02B | +6 | −8 |
| Q4 2025 | 118 | 0 | 48.22M | $5.44B | +2 | −1 |
| Q3 2025 | 22 | +5 | 29.69M | $2.42B | +5 | −1 |
| Q2 2025 | 15 | -2 | 32.65M | $3.37B | +1 | −3 |
| Q1 2025 | 14 | -2 | 8.81M | $867.57M | +1 | −3 |
| Q4 2024 | 16 | -1 | 9.74M | $1.46B | — | −1 |
| Q3 2024 | 16 | 0 | 7.06M | $919.99M | +1 | −1 |
| Q2 2024 | 16 | — | 6.75M | $798.69M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.29M | +6.1% | $225.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.29M | +6.1% | $225.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.29M | +6.1% | $225.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.29M | +6.1% | $225.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.29M | +6.1% | $225.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (被动) | 1.98M | -3.8% | $195.30M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 1.22M | +0.3% | $119.92M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.22M | +1.5% | $119.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 1.22M | +1.5% | $119.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 654.93K | +16.2% | $64.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Capital World Investors ✦ | 550.32K | 0.0% | $54.16M | 0.0% | Held | 4 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 420.50K | -64.8% | $41.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 420.50K | -64.8% | $41.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Marshall Wace ✦ | 344.77K | 新增 | $33.93M | 0.0% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 344.77K | 新增 | $33.93M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 344.77K | 新增 | $33.93M | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 344.77K | 新增 | $33.93M | 0.0% | New | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 78.23K | -80.1% | $7.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 37.77K | +7.3% | $3.72M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 7.79K | +2.6% | $766,495 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 7.79K | +2.6% | $766,495 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 7.79K | +2.6% | $766,495 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 7.79K | +2.6% | $766,495 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | GAMCO Investors ✦ | 7.23K | +38.8% | $711,380 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 2.36K | -59.5% | $231,878 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 2.10K | -22.2% | $206,780 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $33.93M | 0.0% |
| Marshall Wace | $33.93M | 0.0% |
| Marshall Wace | $33.93M | 0.0% |
| Marshall Wace | $33.93M | 0.0% |
已清仓
| Point72 Asset Management | $42.03M | 曾为 0.1% |
| Renaissance Technologies | $7.44M | 曾为 0.0% |
| Adage Capital Partners | $3.51M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 333 持有人, 57.55M 股份, $6.09B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Kliman Gilbert H
Director · 2.50K 股 · $475,000
Aug 11
Gilliam Joseph E
Officer · 27.96K 股 · $5.00M
Aug 11
Gilliam Joseph E
Officer · 32.04K 股 · $5.78M
Aug 07
Thurman Alex R.
Officer · 20.00K 股 · $3.60M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据